Biomedicine

Found results: 2481

Biomedicine

Mircludex B against hepatitis B

The company "Hepatera" begins conducting a clinical trial of the Ib-IIa phase of the drug Mircludex B, intended for the treatment of chronic viral hepatitis B.

13.12.2012
Biomedicine

Blood Cancer Treatment: Let lymphocytes kill each other

The method of reprogramming the patient's T-lymphocytes so that their target is cancer B-lymphocytes can revolutionize the approach to the treatment of leukemia and other types of blood cancers. In addition, it opens up prospects for the treatment of malignant neoplasms of other organs.

12.12.2012
Biomedicine

Prostaglandin E2 accelerates bone marrow recovery

The introduction of prostaglandin E2 accelerates the restoration of hematopoiesis in the bone marrow affected by chemotherapy and /or radiotherapy, not only by suppressing apoptosis of hematopoietic cells, but also by restoring their microenvironment.

12.12.2012
Biomedicine

Therapeutic vaccines: Top 10

Ten of the most promising of the many therapeutic vaccines at different stages of development and clinical research against various forms of cancer, AIDS, Alzheimer's disease, multiple sclerosis, rheumatoid arthritis and other serious diseases.

10.12.2012
Biomedicine

Opioid peptides for topical use

The treatment of pain caused by inflammation can be improved with the help of endogenous opioid peptides acting outside the brain or spinal cord, directly in the damaged tissue.

10.12.2012
Biomedicine

Brown fat and obesity: light at the end of the tunnel?

The researchers plan to continue studying the functions of Tyk2 and Stat3 proteins in order to gain a more complete understanding of the mechanisms of formation of brown adipose tissue. They hope that their work will provide new targets not only for the treatment of obesity, but also for the prevention of diseases associated with it.

07.12.2012
Biomedicine

How to feed cancer cells with poison

Scientists at the Whitehead Institute believe that hyperexpression of specific molecular transporters on their surface can be used to deliver drugs to cancer cells.

07.12.2012
Biomedicine

Ganglioside GM1 against Parkinson's disease

A clinical study involving 77 patients demonstrated positive results of the use of a new experimental drug ganglioside GM1 in the treatment of Parkinson's disease.

06.12.2012
Biomedicine

Blood test for all types of cancer: one more step

We can hope for the rapid introduction into clinical practice of a test that allows us to diagnose all types of cancer at the earliest stage by detecting fragments of extracellular tumor DNA circulating in the bloodstream containing chromosomal abnormalities.

30.11.2012
Biomedicine

New hope in the treatment of Alzheimer's disease

The new approach, which consists in blocking one of the signaling molecules of the immune system, significantly reduces the severity of changes characteristic of Alzheimer's disease.

27.11.2012
Biomedicine

Telomerase is a potential target of antitumor therapy

The enzyme telomerase is the cause of chronic inflammation in malignant diseases. Reducing its activity with the help of pharmaceuticals can reduce the dosage of traditional chemotherapy drugs.

26.11.2012
Biomedicine

Diabetes Medication Helps with Alzheimer's Disease

Rosiglitazone, approved by the FDA for the treatment of insulin resistance in patients with type 2 diabetes, may improve the cognitive function of patients with Alzheimer's disease.

23.11.2012